Urinary incontinence: An unrecognised adverse effect with donepezil

M. Hashimoto; T. Imamura; S. Tanimukai; H. Kazui; Etsuro Mori

doi:10.1016/S0140-6736(00)02588-5

Urinary incontinence: An unrecognised adverse effect with donepezil

M. Hashimoto, T. Imamura, S. Tanimukai, H. Kazui, Etsuro Mori

医学系研究科・障害科学専攻

研究成果: Article › 査読

79 被引用数 (Scopus)

抄録

Donepezil has been licensed for use in Japan to improve cognitive function since 1999. Among 94 patients with probable Alzheimer's disease who we treated with donepezil, seven patients developed urinary incontinence, although this event was transient in most patients.

本文言語	English
ページ数	1
ジャーナル	Lancet
巻	356
号	9229
DOI	https://doi.org/10.1016/S0140-6736(00)02588-5
出版ステータス	Published - 2000 8 12

ASJC Scopus subject areas

Medicine(all)

文献へのアクセス

10.1016/S0140-6736(00)02588-5

フィンガープリント「Urinary incontinence: An unrecognised adverse effect with donepezil」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

@article{16b5c819fd08478e8770d8ae9ed858c8,

title = "Urinary incontinence: An unrecognised adverse effect with donepezil",

abstract = "Donepezil has been licensed for use in Japan to improve cognitive function since 1999. Among 94 patients with probable Alzheimer's disease who we treated with donepezil, seven patients developed urinary incontinence, although this event was transient in most patients.",

author = "M. Hashimoto and T. Imamura and S. Tanimukai and H. Kazui and Etsuro Mori",

year = "2000",

month = aug,

day = "12",

doi = "10.1016/S0140-6736(00)02588-5",

language = "English",

volume = "356",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9229",

}

TY - JOUR

T1 - Urinary incontinence

T2 - An unrecognised adverse effect with donepezil

AU - Hashimoto, M.

AU - Imamura, T.

AU - Tanimukai, S.

AU - Kazui, H.

AU - Mori, Etsuro

PY - 2000/8/12

Y1 - 2000/8/12

N2 - Donepezil has been licensed for use in Japan to improve cognitive function since 1999. Among 94 patients with probable Alzheimer's disease who we treated with donepezil, seven patients developed urinary incontinence, although this event was transient in most patients.

AB - Donepezil has been licensed for use in Japan to improve cognitive function since 1999. Among 94 patients with probable Alzheimer's disease who we treated with donepezil, seven patients developed urinary incontinence, although this event was transient in most patients.

UR - http://www.scopus.com/inward/record.url?scp=0034641560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034641560&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(00)02588-5

DO - 10.1016/S0140-6736(00)02588-5

M3 - Article

C2 - 10950240

AN - SCOPUS:0034641560

VL - 356

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9229

ER -